MBX

← Markets

MBXMBX Biosciences, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Thu, Aug 27
7:00 AMglobenewswire.comMBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
Thu, Aug 6
7:00 AMYahooMBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
Mon, Jul 13
3:15 PMYahooMBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
Mon, Jun 15
3:14 PMYahooHow Do MBX Biosciences’ (MBX) Phase 2 Results Reframe Its Long-Term Hypoparathyroidism Strategy?
Fri, Jun 12
7:52 AMinvestorshub.advfn.comMBX Biosciences Shares Fall Despite Positive One-Year Trial Results for Canvuparatide (MBX)
6:00 AMYahooMBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism
Mon, Jun 1
7:00 AMYahooMBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026
Wed, May 27
2:38 PMfool.comChief Medical Officer Sells MBX for $2.7 Million After Monster 2026 Run
Tue, May 26
7:00 AMYahooMBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City
Fri, May 15
8:18 AMYahooInsider Stock Buying Reaches US$1.06m On MBX Biosciences
Mon, May 11
2:09 PMmarketbeat.comMBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline Push
6:00 AMYahooMBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing